Assessment of the availability of oral drugs for the treatment of type 2 diabetes mellitus in Novosibirsk pharmacies
https://doi.org/10.31549/2542-1174-2022-6-3-15-22
Abstract
I n t r o d u c t i o n . The availability of drugs for the treatment of diabetes mellitus in pharmacies requires special attention and is an important indicator of the quality of pharmaceutical care provided to patients with diabetes mellitus on an outpatient basis.
A i m . To assess the availability of oral drugs for the treatment of type 2 diabetes mellitus (T2DM) in Novosibirsk pharmacies.
M a t e r i a l s a n d m e t h o d s . The objects of the study were current databases of Novosibirsk pharmacies, data from the State Register of Medicines. The retail availability and affordability of drugs for the treatment of T2DM were assessed. We used the content analysis, statistical method, and comparison method.
R e s u l t s . The retail availability of the majority of drugs for the treatment of T2DM was low. Among the drugs with low availability, the largest part is occupied by combinations of oral hypoglycemic drugs (31.91%). More than half the drugs were unaffordable. The least affordable medications were combinations of oral hypoglycemic drugs (35% of the amount of unaffordable medicial products) and renal glucose reabsorption inhibitors (11.67% of the total amount of unaffordable drugs).
C o n c l u s i o n . The results obtained, which revealed the insufficient retail availability and affordability of oral drugs for the treatment of type 2 diabetes mellitus, may serve as a basis for further research to improve pharmaceutical care for patients with diabetes mellitus.
About the Authors
I. A. Kharina
Novosibirsk State Medical University
Russian Federation
Russian Federation
Inna A. Kharina – Post-graduate Student, Lecturer, Department of Management and Economics of Pharmacy, Medical and Pharmaceutical Commodity Science, Novosibirsk State Medical University.
Novosibirsk.
I. A. Dzhuparova
Novosibirsk State Medical University
Russian Federation
Russian Federation
Irina A. Dzhuparova – Dr. Sci. (Pharmaceut.), Associate Professor, Head, Department of Management and Economics of Pharmacy, Medical and Pharmaceutical Commodity Science, Novosibirsk State Medical University.
Novosibirsk.
References
1. Dzhuparova I.A. (2013). Theoretical and methodological foundations for the development of a pharmacological and geographical model for the modernization of the drug management system for patients with major diseases at the regional level. Dr. Sci. (Pharmaceut.) Thesis. Novosibirsk. 466 p. (In Russ.)
2. Reichtman T.V. (2018). Improving state mechanisms for managing the availability of drug care. Dr. Sci. (Pharmaceut.) Thesis. Moscow. 372 p. (In Russ.)
3. Semionova A.D. (2014). Development of organizational technologies of pharmaceutical care for outpatients (on the example of diabetes mellitus). Cand. Sci. (Pharmaceut.) Thesis. Perm. 263 p. (In Russ.)
4. Murashko M.A., Pakhomenko D.V., Kosenko V.V., Krupnova I.V. Ensuring the quality of medicines for medical use in the Russian Federation. Vestnik Roszdravnadzora. 2015;1:6–16.
5. On approval of the List of Vital and Essential Drugs, as well as the lists of drugs for medical use and the minimum range of medicines necessary for the provision of medical care: Order of the Government of the Russian Federation of 12.10.2019 No. 2406-r. URL: http://www.consultant.ru/document/cons_doc_LAW_335635/ (accessed 01.12.2021).
6. Samko G.N. (2018). Development of object-oriented technologies of increasing the availability and transparency of the pharmaceutical system in the Pridnestrovian Moldavian Republic. Cand. Sci. (Pharmaceut.) Thesis. Moscow. 197 p. (In Russ.)
Review
For citations:
Kharina I.A., Dzhuparova I.A. Assessment of the availability of oral drugs for the treatment of type 2 diabetes mellitus in Novosibirsk pharmacies. Journal of Siberian Medical Sciences. 2022;(3):15-22. https://doi.org/10.31549/2542-1174-2022-6-3-15-22
Views:
115
Email this article 